NET PROFIT (x1000 DKK)
EMPLOYEES
Biomediq A/S
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-65
|
-58
|
-24 |
| Total assets |
40
|
119
|
226 |
| Current assets |
40
|
119
|
226 |
| Current liabilities |
42
|
47
|
53 |
| Equity capital |
-2
|
54
|
113 |
| - share capital |
400
|
400
|
400 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-5.0%
|
45.4%
|
50.0% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
95.2%
|
253.2%
|
426.4% |
| Return on equity (ROE) |
3250.0%
|
-107.4%
|
-21.2% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.